Outcome of patients with accelerated and blast-phase myeloproliferative neoplasms not eligible for intensive chemotherapy or allogeneic hematopoietic cell transplantation treated by azacitidine alone or in combination-A FIM study
一项FIM研究评估了不适合接受强化化疗或异基因造血干细胞移植的加速期和急变期骨髓增殖性肿瘤患者接受阿扎胞苷单药或联合治疗的疗效。
期刊:Hemasphere
影响因子:14.6
doi:10.1002/hem3.70202
Orvain, Corentin; Tavitian, Suzanne; Mediavilla, Clémence; Boyer, Françoise; Santagostino, Alberto; Venton, Geoffroy; Madene, Samia; Marchand, Tony; Turlure, Pascal; Lara, Diane; Le Clech, Lenaig; Le Du, Katell; Robin, Jean-Baptiste; Willems, Lise; Blouet, Anaïse; Systchenko, Thomas; Wemeau, Mathieu; Pasquer, Hélène; Mercier, Mélanie; Nicol, Christophe; Legros, Laurence; Machet, Antoine; Nicolini, Franck-Emmanuel; Roy, Lydia; Salvado, Clémentine; Denis, Guillaume; Lestang, Elsa; Laribi, Kamel; Luque Paz, Damien; Kiladjian, Jean-Jacques; Lippert, Eric; Benajiba, Lina; Ianotto, Jean-Christophe
